Advertisement
Screener

BRUKER CORPORATION (BRKR) Goodwill, Foreign Currency Translation Gain (Loss)

2.8 / 5 stars · 64/116 Roast Me

BRUKER CORPORATION Goodwill, Foreign Currency Translation Gain (Loss)

BRUKER CORPORATION (BRKR) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$18.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Other Income

us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-05

  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$7.20M, a 110.70% decline year-over-year.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$11.20M, a 144.09% decline year-over-year.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$600.00K.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$2.40M, a 107.29% decline year-over-year.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for fiscal 2025 was $89.70M.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$33.60M, a 311.32% decline from fiscal 2023.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for fiscal 2023 was $15.90M.
  • BRUKER CORPORATION goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$13.80M.
Period endGoodwill, Foreign Currency Translation Gain (Loss) 3 monthGoodwill, Foreign Currency Translation Gain (Loss) 6 monthGoodwill, Foreign Currency Translation Gain (Loss) 9 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 month
2026-06-30-$7.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$18.40M
10-Q · filed 2026-08-05
-$19.00M
derived: sum of 3 quarters · filed 2026-08-05
-$21.40M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$11.20M
10-Q · filed 2026-05-07
-$11.80M
derived: sum of 2 quarters · filed 2026-05-07
-$14.20M
derived: sum of 3 quarters · filed 2026-05-07
$53.10M
derived: sum of 4 quarters · filed 2026-05-07
2025-12-31-$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$3.00M
derived: sum of 2 quarters · filed 2026-02-27
$64.30M
derived: sum of 3 quarters · filed 2026-02-27
$89.70M
10-K · filed 2026-02-27
2025-09-30-$2.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$64.90M
derived: sum of 2 quarters · filed 2025-11-05
$90.30M
10-Q · filed 2025-11-05
$38.70M
derived: sum of 4 quarters · filed 2026-02-27
2025-06-30$67.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$92.70M
10-Q · filed 2025-08-06
$41.10M
derived: sum of 3 quarters · filed 2026-02-27
$74.00M
derived: sum of 4 quarters · filed 2026-02-27
2025-03-31$25.40M
10-Q · filed 2025-05-07
-$26.20M
derived: sum of 2 quarters · filed 2026-02-27
$6.70M
derived: sum of 3 quarters · filed 2026-02-27
$5.60M
derived: sum of 4 quarters · filed 2026-02-27
2024-12-31-$51.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$18.70M
derived: sum of 2 quarters · filed 2026-02-27
-$19.80M
derived: sum of 3 quarters · filed 2026-02-27
-$33.60M
10-K · filed 2026-02-27
2024-09-30$32.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$31.80M
derived: sum of 2 quarters · filed 2024-11-07
$18.00M
10-Q · filed 2024-11-07
$35.40M
derived: sum of 4 quarters · filed 2025-03-03
2024-06-30-$1.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$14.90M
10-Q · filed 2024-08-09
$2.50M
derived: sum of 3 quarters · filed 2025-03-03
-$6.90M
derived: sum of 4 quarters · filed 2025-03-03
2024-03-31-$13.80M
10-Q · filed 2024-05-10
$3.60M
derived: sum of 2 quarters · filed 2025-03-03
-$5.80M
derived: sum of 3 quarters · filed 2025-03-03
-$2.60M
derived: sum of 4 quarters · filed 2025-03-03
2023-12-31$17.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$8.00M
derived: sum of 2 quarters · filed 2025-03-03
$11.20M
derived: sum of 3 quarters · filed 2025-03-03
$15.90M
10-K · filed 2025-03-03
2023-09-30-$9.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$6.20M
derived: sum of 2 quarters · filed 2023-11-09
-$1.50M
10-Q · filed 2023-11-09
$17.40M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$3.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$7.90M
10-Q · filed 2023-08-09
$26.80M
derived: sum of 3 quarters · filed 2025-03-03
$12.10M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$4.70M
10-Q · filed 2023-05-10
$23.60M
derived: sum of 2 quarters · filed 2025-03-03
$8.90M
derived: sum of 3 quarters · filed 2025-03-03
-$3.80M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$18.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$4.20M
derived: sum of 2 quarters · filed 2025-03-03
-$8.50M
derived: sum of 3 quarters · filed 2025-03-03
-$13.80M
10-K · filed 2025-03-03
2022-09-30-$14.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
-$27.40M
derived: sum of 2 quarters · filed 2022-11-04
-$32.70M
10-Q · filed 2022-11-04
-$34.70M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$12.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$18.00M
10-Q · filed 2022-08-05
-$20.00M
derived: sum of 3 quarters · filed 2024-02-29
-$23.70M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$5.30M
10-Q · filed 2022-05-06
-$7.30M
derived: sum of 2 quarters · filed 2024-02-29
-$11.00M
derived: sum of 3 quarters · filed 2024-02-29
-$9.40M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$5.70M
derived: sum of 2 quarters · filed 2024-02-29
-$4.10M
derived: sum of 3 quarters · filed 2024-02-29
-$10.90M
10-K · filed 2024-02-29
2021-09-30-$3.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$2.10M
derived: sum of 2 quarters · filed 2021-11-05
-$8.90M
10-Q · filed 2021-11-05
-$1.70M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$1.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$5.20M
10-Q · filed 2021-08-05
$2.00M
derived: sum of 3 quarters · filed 2023-03-01
$8.00M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$6.80M
10-Q · filed 2021-05-10
$400.00K
derived: sum of 2 quarters · filed 2023-03-01
$6.40M
derived: sum of 3 quarters · filed 2023-03-01
$9.90M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$7.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$13.20M
derived: sum of 2 quarters · filed 2023-03-01
$16.70M
derived: sum of 3 quarters · filed 2023-03-01
$13.70M
10-K · filed 2023-03-01
2020-09-30$6.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$9.50M
derived: sum of 2 quarters · filed 2020-11-06
$6.50M
10-Q · filed 2020-11-06
$10.80M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$3.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$500.00K
10-Q · filed 2020-08-07
$4.80M
derived: sum of 3 quarters · filed 2022-02-28
-$900.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$3.00M
10-Q · filed 2020-05-11
$1.30M
derived: sum of 2 quarters · filed 2022-02-28
-$4.40M
derived: sum of 3 quarters · filed 2022-02-28
-$2.70M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$1.40M
derived: sum of 2 quarters · filed 2022-02-28
$300.00K
derived: sum of 3 quarters · filed 2022-02-28
-$2.40M
10-K · filed 2022-02-28
2019-09-30-$5.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04
-$4.00M
derived: sum of 2 quarters · filed 2019-11-04
-$6.70M
10-Q · filed 2019-11-04
-$7.90M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$1.00M
10-Q · filed 2019-08-09
-$2.20M
derived: sum of 3 quarters · filed 2021-03-01
-$2.40M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$2.70M
10-Q · filed 2019-05-08
-$3.90M
derived: sum of 2 quarters · filed 2021-03-01
-$4.10M
derived: sum of 3 quarters · filed 2021-03-01
-$7.10M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$1.40M
derived: sum of 2 quarters · filed 2021-03-01
-$4.40M
derived: sum of 3 quarters · filed 2021-03-01
-$3.10M
10-K · filed 2021-03-01
2018-09-30-$200.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$3.20M
derived: sum of 2 quarters · filed 2018-11-09
-$1.90M
10-Q · filed 2018-11-09
-$1.10M
derived: sum of 4 quarters · filed 2020-03-27
2018-06-30-$3.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$1.70M
10-Q · filed 2018-08-09
-$900.00K
derived: sum of 3 quarters · filed 2020-03-27
$1.10M
derived: sum of 4 quarters · filed 2020-03-27
2018-03-31$1.30M
10-Q · filed 2018-05-10
$2.10M
derived: sum of 2 quarters · filed 2020-03-27
$4.10M
derived: sum of 3 quarters · filed 2020-03-27
$6.30M
derived: sum of 4 quarters · filed 2020-03-27
2017-12-31$800.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$2.80M
derived: sum of 2 quarters · filed 2020-03-27
$5.00M
derived: sum of 3 quarters · filed 2020-03-27
$5.40M
10-K · filed 2020-03-27
2017-09-30$2.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$4.20M
derived: sum of 2 quarters · filed 2017-11-09
$4.60M
10-Q · filed 2017-11-09
$2.80M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$2.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$2.60M
10-Q · filed 2017-08-09
$800.00K
derived: sum of 3 quarters · filed 2019-03-01
2017-03-31$400.00K
10-Q · filed 2017-05-10
-$1.40M
derived: sum of 2 quarters · filed 2019-03-01
2016-12-31-$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$1.00M
10-K · filed 2019-03-01
2016-09-30$800.00K
10-Q · filed 2016-11-09
2015-12-31-$3.30M
10-K · filed 2018-03-16
2014-12-31-$4.60M
10-K · filed 2017-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34